Cutler Group’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,400
Closed -$28K 5406
2020
Q3
$28K Hold
10,400
﹤0.01% 2206
2020
Q2
$57K Buy
10,400
+6,400
+160% +$180K ﹤0.01% 1659
2020
Q1
$22K Buy
4,000
+800
+25% +$23K ﹤0.01% 2248
2019
Q4
$1K Buy
+3,200
New +$89.5K ﹤0.01% 3750
2019
Q1
Sell
-3,200
Closed -$6K 4657
2018
Q4
$6K Buy
+3,200
New +$82.2K ﹤0.01% 2852

Other funds holding RXL

Cutler Group's RXL Position: Q1 2022 in Review

Cutler Group sold out of ProShares Ultra Health Care (RXL) in Q1 2022, closing a stake of 200 shares — an estimated $11K sold.

Cutler Group first reported a position in RXL in Q3 2016 and held it in 11 quarters. The position peaked at $144K in Q1 2020. 22 funds tracked by Wall St. Rank hold RXL as of Q1 2022.

  • Cutler Group reported no remaining ProShares Ultra Health Care position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 200 ProShares Ultra Health Care shares in Q1 2022, an estimated $11K.
  • Cutler Group first reported a position in ProShares Ultra Health Care in Q3 2016 and held it in 11 quarters.
  • Cutler Group's ProShares Ultra Health Care position peaked at $144K in Q1 2020.
  • 22 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.